These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

766 related items for PubMed ID: 21872624

  • 1. Transport of drugs across the blood-brain barrier by nanoparticles.
    Wohlfart S, Gelperina S, Kreuter J.
    J Control Release; 2012 Jul 20; 161(2):264-73. PubMed ID: 21872624
    [Abstract] [Full Text] [Related]

  • 2. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?
    Kreuter J.
    Adv Drug Deliv Rev; 2014 May 20; 71():2-14. PubMed ID: 23981489
    [Abstract] [Full Text] [Related]

  • 3. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
    Wohlfart S, Khalansky AS, Gelperina S, Begley D, Kreuter J.
    J Control Release; 2011 Aug 25; 154(1):103-7. PubMed ID: 21616104
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chapter 3 - Colloidal systems for CNS drug delivery.
    Costantino L, Tosi G, Ruozi B, Bondioli L, Vandelli MA, Forni F.
    Prog Brain Res; 2009 Aug 25; 180():35-69. PubMed ID: 20302828
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis.
    Ragnaill MN, Brown M, Ye D, Bramini M, Callanan S, Lynch I, Dawson KA.
    Eur J Pharm Biopharm; 2011 Apr 25; 77(3):360-7. PubMed ID: 21236340
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution.
    Tosi G, Vergoni AV, Ruozi B, Bondioli L, Badiali L, Rivasi F, Costantino L, Forni F, Vandelli MA.
    J Control Release; 2010 Jul 01; 145(1):49-57. PubMed ID: 20338201
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.
    Rempe R, Cramer S, Qiao R, Galla HJ.
    Cell Tissue Res; 2014 Mar 01; 355(3):717-26. PubMed ID: 24585360
    [Abstract] [Full Text] [Related]

  • 20. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL, Wu XY, Bendayan R.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):686-700. PubMed ID: 22100125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.